JPWO2020218121A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020218121A5
JPWO2020218121A5 JP2021516037A JP2021516037A JPWO2020218121A5 JP WO2020218121 A5 JPWO2020218121 A5 JP WO2020218121A5 JP 2021516037 A JP2021516037 A JP 2021516037A JP 2021516037 A JP2021516037 A JP 2021516037A JP WO2020218121 A5 JPWO2020218121 A5 JP WO2020218121A5
Authority
JP
Japan
Prior art keywords
cancer
marker
azu1
antibody
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021516037A
Other languages
English (en)
Japanese (ja)
Other versions
JP7546255B2 (ja
JPWO2020218121A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/016607 external-priority patent/WO2020218121A1/ja
Publication of JPWO2020218121A1 publication Critical patent/JPWO2020218121A1/ja
Publication of JPWO2020218121A5 publication Critical patent/JPWO2020218121A5/ja
Application granted granted Critical
Publication of JP7546255B2 publication Critical patent/JP7546255B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021516037A 2019-04-24 2020-04-15 癌を検出する方法および検出試薬 Active JP7546255B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019082912 2019-04-24
JP2019082912 2019-04-24
PCT/JP2020/016607 WO2020218121A1 (ja) 2019-04-24 2020-04-15 癌を検出する方法および検出試薬

Publications (3)

Publication Number Publication Date
JPWO2020218121A1 JPWO2020218121A1 (https=) 2020-10-29
JPWO2020218121A5 true JPWO2020218121A5 (https=) 2023-04-24
JP7546255B2 JP7546255B2 (ja) 2024-09-06

Family

ID=72942515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021516037A Active JP7546255B2 (ja) 2019-04-24 2020-04-15 癌を検出する方法および検出試薬

Country Status (5)

Country Link
US (1) US20220178932A1 (https=)
EP (1) EP3960758A4 (https=)
JP (1) JP7546255B2 (https=)
CN (1) CN113727995A (https=)
WO (1) WO2020218121A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7661767B2 (ja) * 2021-04-28 2025-04-15 東ソー株式会社 細胞外小胞の検出方法
JPWO2024203968A1 (https=) * 2023-03-24 2024-10-03
WO2025197993A1 (ja) * 2024-03-22 2025-09-25 学校法人東邦大学 テトラスパニン10陽性細胞外小胞の濃縮方法、及びがんを検出する又はがんの予後を予測する方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502522A (en) 1976-11-25 1978-03-01 Gestetner Ltd Stencil ejector on a stencil duplicator
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
JP5663834B2 (ja) 2008-03-14 2015-02-04 東ソー株式会社 遺伝子組換え抗体の製造方法
JP5488885B2 (ja) 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途
KR20140107615A (ko) * 2011-12-26 2014-09-04 시오노기 앤드 컴파니, 리미티드 엑소좀 검출용 모노클로날 항체
WO2013162368A1 (en) * 2012-04-26 2013-10-31 Stichting Vu-Vumc Biomarkers
WO2015083791A1 (ja) * 2013-12-04 2015-06-11 国立研究開発法人理化学研究所 肺癌の検出方法および検出キット
KR102582192B1 (ko) 2014-12-05 2023-09-25 후지필름 가부시키가이샤 Tim 단백질 결합 담체, 당해 담체를 사용한 세포외막소포 및 바이러스의 취득 방법, 제거 방법, 검출 방법 그리고 당해 담체를 포함하는 키트
KR101863951B1 (ko) 2015-11-30 2018-06-01 의료법인 성광의료재단 난소암의 진단 및 치료를 위한 조성물, 키트 및 방법
EP3543701A4 (en) 2016-10-28 2020-07-29 Japanese Foundation For Cancer Research BIOMARKER, METHOD OF SEARCHING FOR A GENE ASSOCIATED WITH A DISEASE, AND MARKER FOR KIDNEY CANCER
US20200408763A1 (en) * 2017-05-23 2020-12-31 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Novel stool-based protein biomarkers for colorectal cancer screening
CN115047182B (zh) * 2017-10-05 2025-03-11 香港科技大学 外泌体分析及癌症诊断方法

Similar Documents

Publication Publication Date Title
JP4594575B2 (ja) がんのマーカーとして使用されるアネキシン類及び自己抗体
EP2698634B1 (en) Biomarker for breast cancer
CN105765386B (zh) 用于检测中和抗体的竞争性配体结合测定法
JP6612414B2 (ja) Pd−l1に対するsrmアッセイ
JPWO2020218121A5 (https=)
JP2017133831A (ja) 大腸がんの転移検出方法
US12473600B2 (en) Marker for pancreatic cancer and intraductal papillary mucinous neoplasms
CN112334487B (zh) 用于诊断和治疗癌症的组合物和方法
Xu et al. Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer
CN111579784B (zh) 以dhps基因作为指标使用的动脉硬化及癌的检测方法
JP6294118B2 (ja) 大腸癌マーカー及び大腸癌検出方法
CN113406328A (zh) CST1、CEA及SCC-Ag在制备食管鳞状细胞癌早期诊断试剂盒中的应用
JPWO2008096767A1 (ja) 肝細胞がんタンパク質マーカーとそれを用いた肝細胞がん検出方法及び装置
JP7709703B2 (ja) 膵臓がんの検出方法及び検出試薬
KR101451227B1 (ko) Pka 활성을 이용한 암 진단용 조성물 및 암 전이 진단을 위한 정보제공 방법
EP2728358B1 (en) Haptoglobin alpha-r as marker for diagnosing lung cancer
JP7565046B2 (ja) がんの骨転移を検出する方法及び検出試薬
KR101636821B1 (ko) Aimp2-dx2 단백질 또는 이의 단편을 포함하는 폐암 진단용 조성물
ITTO20120523A1 (it) Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico
WO2013017891A2 (en) Assay
TWI682175B (zh) 一種用於診斷胃癌的方法
KR20120021518A (ko) 간암 진단용 조성물 및 진단방법
CN108061803B (zh) 肝癌血清标志物cct3
KR20130023308A (ko) 폐암 바이오마커
CN108267593A (zh) 一种基于双分子荧光互补技术的cTnI检测试剂盒、制备及使用方法